Suisselle
Suisselle, founded in 2010 and headquartered in Yverdon-les-Bains, Switzerland, is a science-driven company specializing in the development of high-quality medical aesthetic products. Known for its extensive research and development in the Hyaluronic Acid (HA) domain, Suisselle is committed to innovation and excellence. The company offers a range of advanced injectable boosters, dermal fillers, and cosmeceuticals under its renowned brands, Cellbooster® and Apriline®. Suisselle's patented CHAC Technology stabilizes HA without chemical binding agents, enhancing its bioavailability and efficacy. This technology is pivotal in their products, which include the first CE-marked stabilized complex boosters and new-generation HA fillers designed for long-lasting results. The company operates a state-of-the-art production facility in Switzerland, ensuring all products meet the highest quality standards (ISO 22716, ISO 13485, ISO 9001, and GMP). Suisselle’s products are widely used and trusted by aesthetic professionals worldwide, making them a leading name in the aesthetic industry.
Suisselle Introduction
Based on Switzerland, Suisselle is a cosmetic and medical device products developer, with extensive R&D experience within the Hyaluronic Acid (HA) domain. The Research and Development department is fully dedicated to developing new technologies allowing to develop Innovative aesthetic solutions. Suisselle's products are designed with the patients' safety and skin health in mind and made in accordance with the highest quality standards of cosmetics and medical device manufacturing (ISO 22716, ISO 13485 and ISO 9001 and GMP). One of the most known solutions is the patented CHAC Technology is able to modify and exploit the natural properties of Hyaluronic Acid and make it an optimal vehicle for transporting the essential nutrients to the skin. CELLBOOSTER® is company’s most popular injectable booster, which is the first CE-Marked Stabilized Complex Boosters.